Original Articles
19 February 2025
Vol. 40 No. 1 (2018)
[Chronic diseases in neuromotor rehabilitation medicine]
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
25
Views
18
Downloads
Authors
Chronic diseases are a major problem, whose importance is nowadays raising up. Up to 86% of deaths are directly related to chronic diseases in Europe as they represent large amount of total diseases, with a major impact on global health spending. Patients suffering from heterogeneous disabilities (such as Parkinson's disease, stroke, multiple sclerosis, osteoporosis, osteoarthritis) often show an interaction between the main disease and comorbidity and multimorbidity. Therefore, the complicate interaction between all these ailments must be faced following specific care pathways. Within the latter ones, pharmacological, physicall cognitive and other (surgical and non-surgical) treatments should be reconciled in order to produce a synergic effect to counteract patient's clinical problems. Finally, neuromotor rehabilitation medicine should not only be considered as a step following the acute phase but also as an effective tool of secondary and tertiary prevention aimed to avoid relapses and re-hospitalization as well as to improve patient's quality of life.
Altmetrics
Downloads
Download data is not yet available.
Citations
1) Regione Lombardia, Deliberazione X/4662/2015.
2) Programma Guadagnare Salute - Rendere facili le scelte salutari. Decreto del 4 maggio 2007.
3) Murray SA, Kendall M, Boyd K, et al. Illness trajectories and palliative care. BMJ 2005; 330: 1007-11.
4) Hwang W, Weller W, Ireys H, et al. Out-of-pocket medical spending for care of chronic conditions. Health Aff (Millwood) 2001; 20: 267-78. 5) Friedman B, Jiang HJ, Elixhauser A. Costly hospital readmissions and complex chronic illness. Inquiry 2008-2009; 45: 408-21.
6) Warshaw G. Introduction: advances and challenges in care of older people with chronic illness. Generations 2006; 30: 5-10.
7) ISTAT. Rapporto Annuale 2014.
8) World Health Organization. Global status report on noncommunicable diseases 2014.
9) WHO. Global action plan for the prevention and control of NCDs 2013-2020.
10) National Institute for Statistics. Italian Statistics 2015. Rome: National Institute for Statistics; April 27th, 2015.
11) Regione Lombardia, Deliberazione X/6164/2017.
12) Regione Lombardia, Deliberazione X/6551/2017.
13) Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 2012; 380: 37-43.
14) Fortin M, Stewart M, Poitras ME, et al. A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Ann Fam Med 2012; 10: 142-51.
15) Salisbury C, Johnson L, Purdy S, et al. Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract 2011; 61: el2-e21.
16) Akker MVD, Buntinx F, Knottnerus JA. Comorbidity or multimorbidity: what's in a name? A review of literature. Eur J Gen Pract 1996; 2: 65-70.
17) Violan C, Foguet-Boreu Q, Flores-Mateo G, et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS One 2014; 9: e 102149. 18) Gunn JM, Ayton DR, Densley K, et al. The association between chronic illness, multimorbidity and depressive symptoms in an Australian primary care cohort. Soc Psychiatry Psychiatr Epidemiol 2012; 47: 175-84.
19) Katon WJ, Lin EH, Von KM, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med 2010; 363: 2611-20.
20) Spanevello A, Garbelli C, Giorgi G. Piano della cronicità e cure correlate. Italian Health Policy Brief 2016; 3: 1-6.
21) Poewe W, Seppi K, Tanner CM, Halliday GM, et al. Parkinson disease. Nat Rev Dis Primers 2017; 3: 17013.
22) Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci 2017; 18: 435-50.
23) Olanow CW, Watts RL, Koller WC. An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines. Neurology 2001; 56: S1-88.
24) Cusso ME, Donald KJ, Khoo TK. The Impact of Physical Activity on Non-Motor Symptoms in Parkinson's Disease: A Systematic Review. Front Med (Lausanne) 2016; 3: 35.
25) Neeper SA, Gomez-Pinilla F, Choi J, et al. Exercise and brain neurotrophins. Nature 1995; 373: 109.
26) Neeper SA, Gomez-Pinilla F, Choi J, et al. Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res 1996; 726: 49-56.
27) Zigmond MJ, Smeyne RJ. Exercise: is it a neuroprotective and if so, how does it work? Parkinsonism Relat Disord 2014; 20 Suppl 1: S123-7.
28) Allen NE, Schwarzel AK, Canning CG. Recurrent falls in Parkinson's disease: a systematic review. Parkinsons Dis 2013; 2013: 906274.
29) Michalowska M, Fiszer U, Krygowska-Wajs A, et al. Falls in Parkinson's disease. Causes and impact on patients' quality of life. Funct Neurol 2005; 20: 163-8.
30) Diagnosi e terapia della malattia di Parkinson. Linea Guida 24, Istituto Superiore di Sanità, 2013, Roma.
31) Fil A, Cano-de-la-Cuerda R, Muñoz-Hellín E, et al. Pain in Parkinson disease: a review of the literature. Parkinsonism Relat Disord 2013; 19: 285-94.
32) Sophie M, Ford B. Management of pain in Parkinson's disease. CNS Drugs 2012; 26: 937-48.
33 SPREAD: Stroke Prevention and Educational Awareness Diffusion. Ictus cerebrale: linee guida italiane di prevenzione e trattamento, VIII Edizione, 2016, www.iso-spread.it.
34) Gresham GE, Phillips TF, Wolf PA, et al. Epidemiologic profile of long-term stroke disability: the Framingham study. Arch Phys Med Rehabil 1979; 60: 487-91.
35) Klit H, Brix Finnerup N, Andersen G, et al. Central poststroke pain: A population-based study. Pain 2011; 152: 818-24.
36) Mandliya A, Das A, Unnikrishnan JP, et al. Post-stroke Fatigue is an Independent Predictor of Post-stroke Disability and Burden of Care: A Path analysis Study. Top Stroke Rehabil 2016; 23: 1-7.
37) Delva II, Lytvynenko NV, Delva MY. Post-stroke fatigue and its dimensions within first 3 months after stroke. Wiad Lek 2017; 70: 43-46.
38) Wu S, Kutlubaev MA, Chun HY, et al. Interventions for post-stroke fatigue. Cochrane Database Syst Rev 2015; CD007030.
39) Buch ER, Santarnecchi E, Antal A, et al. Effects of tDCS on motor learning and memory formation: A consensus and critical position paper. Clin Neurophysiol 2017; 128: 589-603.
40) www.epicentro.iss.it.
41) Katz Sand I. Classification, diagnosis, and differential diagnosis of multiple sclerosis. Curr Opin Neurol 2015; 28: 193-205.
42) Pawate S, Bagnato F. Newer agents in the treatment of multiple sclerosis. Neurologist 2015; 19: 104-17.
43) Lincoln NB, das Nair R, Bradshaw L, et al. Cognitive Rehabilitation for Attention and Memory in people with Multiple Sclerosis: study protocol for a randomised controlled trial (CRAMMS). Trials 2015; 16: 556.
44) Yu CH, Mathiowetz V. Systematic review of occupational therapyrelated interventions for people with multiple sclerosis: part 1. Activity and participation. Am J Occup Ther 2014; 68: 27-32. 45) Marrie RA, Cutter G, Tyry T, et al. A cross-sectional study of bone health in multiple sclerosis. Neurology 2009; 73: 1394-8.
46) Cosman F, Nieves J, Komar L, et al. Fracture history and bone loss in patients with MS. Neurology 1998; 51: 1161-5.
47) Weinstock-Guttman B, Gallagher E, Baier M, et al. Risk of bone loss in men with multiple sclerosis. Mult Scler 2004; 10: 170-5.
48) Nilsagard Y, Lundholm C, Denison E, et al. Predicting accidental falls in people with multiple sclerosis: a longitudinal study. Clin Rehabil 2009; 23: 259-69.
49) Ozgocmen S, Bulut S, Ilhan N, et al. Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity. J Bone Miner Metab 2005; 23: 309-13.
50) Formica CA, Cosman F, Nieves J, et al. Reduced bone mass and fatfree mass in women with multiple sclerosis: effects of ambulatory status and glucocorticoid use. Calcif Tissue Int 1997; 61: 129-33.
51) Dovio A, Perazzolo L, Osella G, et al. Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis. J Clin Endocrinol Metab 2004; 89: 4923-8. 52) Cattaneo D, De Nuzzo C, Fascia T, et al. Risks of falls in subjects with multiple sclerosis. Arch Phys Med Rehabil 2002; 83: 864-7. 53) Bazelier MT, van Staa T-P, Uitdehaag BMJ, et al. Risk of fractures in patients with multiple sclerosis: A population-based cohort study. Neurology 2012; 78: 1967-73.
54) Hudec SM, Camacho PM. Secondary causes of osteoporosis. Endocr Pract 2013; 19: 120-128.
55) Rossini M, Adami S, Bertoldo F, et al. Linee guida per la diagnosi, la prevenzione ed il trattamento dell'osteoporosi. Reumatismo, 2016; 68: 1-42.
56) Dyer SM, Crotty M, Fairhall N, et al. Fragility Fracture Network (FFN) Rehabilitation Research Special Interest Group. A critical review of the long-term disability outcomes following hip fracture. BMC Geriatr 2016; 16: 158.
57) Cross M, Smith E, Hoy D, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 2014; 73: 1323-30.
58) Hunter DJ, Schofield D, Callander E. The individual and socioeconomic impact of osteoarthritis. Nat Rev Rheumatol 2014; 10: 437-41. 59) Meneses SR, Goode AP, Nelson AE, et al. Clinical algorithms to aid osteoarthritis guideline dissemination. Osteoarthritis Cartilage 2016; 24: 1487-99.
60) Allen KD, Choong PF, Davis AM, et al. Osteoarthritis: Models for appropriate care across the disease continuum. Best Pract Res Clin Rheumatol 2016; 30: 503-35.
61) Guthrie B, Payne K, Alderson P, et al. Adapting clinical guidelines to take account of multimorbidity. BMJ 2012; 345: e6341.
62) Nardone A, Schieppati M. The role of instrumental assessment of balance in clinical decision making. Eur J Phys Rehabil Med 2010; 46: 221-37.
63) Dhawan A, Mather 3rd RC, Karas V, et al. An epidemiologic analysis of clinical practice guidelines for non-arthroplasty treatment of osteoarthritis of the knee. Arthroscopy 2014; 30: 65-71. 64) Thorstensson CA, Garellick G, Rystedt H, et al. Better management of patients with osteo-arthritis: development and nationwide implementation of an evidence-based supported osteoar-thritis selfmanagement programme. Musculoskelet Care 2015; 13: 67-75. 65) Li LC, Sayre EC, Kopec JA, et al. Quality of nonpharmacological care in the community for people with knee and hip osteoarthritis. J Rheumatol 2011; 38: 2230-7.
66) Paskins Z, Sanders T, Croft PR, et al. The identity crisis of osteoarthritis in general practice: a qualitative study using videostimulated recall. Ann Fam Med 2015; 13: 537-44.
67) Rubenstein LZ, Josephson KR. The epidemiology of falls and syncope. Clin Geriatr Med 2002; 18: 141-58.
68) Tinetti ME, Kumar C. The patient who falls: "it's always a tradeoff". JAMA 2010; 303: 258-66.
69) Payne RA, Avery AJ, Duerden M, et al. Prevalence of polypharmacy in a Scottish primary care population. Eur J Clin Pharmacol 2014; 70: 575-81.
70) Gillespie LD, Robertson MC, Gillespie WJ, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2009: CD007146.
71) De Labra C, Guimaraes-Pinheiro C, Maseda A, L et al. Effects of physical exercise interventions in frail older adults: a systematic review of randomized controlled trials. BMC Geriatr 2015; 15: 154.
How to Cite
[Chronic diseases in neuromotor rehabilitation medicine]. (2025). Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia, 40(1), 48-55. https://doi.org/10.4081/gimle.531
Copyright (c) 2018 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.